Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
FAQs
Advertising
Report Store
UsernamePublicRestriction
Tags:

Reimportation Future Debate Could Focus On State Initiatives

  • News

Executive Summary

The next phase of the prescription drug reimportation debate could include discussion of state efforts to facilitate personal imports

You may also be interested in...



Rx Imports From Canada Reimbursed By Minnesota Health Plan

HealthPartners is reimbursing members for prescription drugs they purchase from Canadian pharmacies, Senior Health Plan Counsel Claire Zajac told an American Conference Institute meeting in Washington, D.C. March 23

Rx Imports From Canada Reimbursed By Minnesota Health Plan

HealthPartners is reimbursing members for prescription drugs they purchase from Canadian pharmacies, Senior Health Plan Counsel Claire Zajac told an American Conference Institute meeting in Washington, D.C. March 23

AARP Wants HHS Price Negotiation If Medicare Discounts Are Insufficient

AARP would work to give HHS negotiating authority on Medicare drug prices if discounts negotiated by private plans and manufacturers are inadequate

Table

View full table

Related Content

Pink Sheet
Pink Sheet
Pink Sheet
Tags:
UsernamePublicRestriction

Register

ID036688

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By